Evaluation of Reference variability [Design Issues]

posted by Nirali – India, 2009-04-17 09:38 (6276 d 06:40 ago) – Posting: # 3551
Views: 5,605

Thank you friends.

Actually, we got the proposal to evaluate reference variability using below design:
"2-period replicate design to assess the intra-subject variability of reference drug, in which reference drug given in both the periods".

Shall it be appropriate design to evaluate reference variability for EU regulatory? :confused:

Regards,
NIRALI

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
149 visitors (0 registered, 149 guests [including 25 identified bots]).
Forum time: 16:19 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5